Proquest Investments Iv, L.p. - Net Worth and Insider Trading
Proquest Investments Iv, L.p. Net Worth
The estimated net worth of Proquest Investments Iv, L.p. is at least $43 Million dollars as of 2024-05-29. Proquest Investments Iv, L.p. is the 10% Owner of UroGen Pharma Ltd and owns about 1,242,031 shares of UroGen Pharma Ltd (URGN) stock worth over $17 Million. Proquest Investments Iv, L.p. is the 10% Owner of Eagle Pharmaceuticals Inc and owns about 3,614,138 shares of Eagle Pharmaceuticals Inc (EGRX) stock worth over $14 Million. Proquest Investments Iv, L.p. is also the 10% Owner of Immune Design Corp and owns about 1,983,858 shares of Immune Design Corp (IMDZ) stock worth over $12 Million. Details can be seen in Proquest Investments Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Proquest Investments Iv, L.p. has not made any transactions after 2017-11-28 and currently still holds the listed stock(s).
Transaction Summary of Proquest Investments Iv, L.p.
Proquest Investments Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Proquest Investments Iv, L.p. owns 5 companies in total, including UroGen Pharma Ltd (URGN) , Eagle Pharmaceuticals Inc (EGRX) , and Agile Therapeutics Inc (AGRX) among others .
Click here to see the complete history of Proquest Investments Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of Proquest Investments Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2017-11-28 | 10 percent owner |
| EGRX | Eagle Pharmaceuticals Inc | 2017-04-25 | 10 percent owner |
| AGRX | Agile Therapeutics Inc | 2014-05-22 | 10 percent owner |
 | | 2015-05-12 | 10 percent owner |
| | 2009-12-16 | 10 percent owner |
Proquest Investments Iv, L.p. Latest Holdings Summary
Proquest Investments Iv, L.p. currently owns a total of 3 stocks. Among these stocks, Proquest Investments Iv, L.p. owns 1,242,031 shares of UroGen Pharma Ltd (URGN) as of November 28, 2017, with a value of $17 Million and a weighting of 39.59%. Proquest Investments Iv, L.p. owns 3,614,138 shares of Eagle Pharmaceuticals Inc (EGRX) as of April 25, 2017, with a value of $14 Million and a weighting of 33.21%. Proquest Investments Iv, L.p. also owns 1,983,858 shares of Immune Design Corp (IMDZ) as of May 12, 2015, with a value of $12 Million and a weighting of 27.2%.
Latest Holdings of Proquest Investments Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2017-11-28 | 1,242,031 | 13.60 | 16,891,622 |
| EGRX | Eagle Pharmaceuticals Inc | 2017-04-25 | 3,614,138 | 3.92 | 14,167,421 |
| IMDZ | Immune Design Corp | 2015-05-12 | 1,983,858 | 5.85 | 11,605,569 |
Holding Weightings of Proquest Investments Iv, L.p.
Proquest Investments Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Proquest Investments Iv, L.p. has made a total of 0 transactions in UroGen Pharma Ltd (URGN) over the past 5 years. The most-recent trade in UroGen Pharma Ltd is the sale of 209,298 shares on November 28, 2017, which brought Proquest Investments Iv, L.p. around $8 Million.
According to the SEC Form 4 filings, Proquest Investments Iv, L.p. has made a total of 0 transactions in Eagle Pharmaceuticals Inc (EGRX) over the past 5 years. The most-recent trade in Eagle Pharmaceuticals Inc is the sale of 54,180 shares on April 25, 2017, which brought Proquest Investments Iv, L.p. around $5 Million.
According to the SEC Form 4 filings, Proquest Investments Iv, L.p. has made a total of 0 transactions in Immune Design Corp (IMDZ) over the past 5 years. The most-recent trade in Immune Design Corp is the sale of 177,607 shares on May 12, 2015, which brought Proquest Investments Iv, L.p. around $4 Million.
Insider Trading History of Proquest Investments Iv, L.p.
- 1
Proquest Investments Iv, L.p. Trading Performance
Proquest Investments Iv, L.p. Ownership Network
Proquest Investments Iv, L.p. Owned Company Details
What does UroGen Pharma Ltd do?
Who are the key executives at UroGen Pharma Ltd?
Proquest Investments Iv, L.p. is the 10 percent owner of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include Chief Medical Officer Mark Schoenberg , General Counsel Jason Drew Smith , and Chief Financial Officer Dong Kim .
UroGen Pharma Ltd (URGN) Insider Trades Summary
Over the past 18 months, Proquest Investments Iv, L.p. made no insider transaction in UroGen Pharma Ltd (URGN). Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 21,478 shares made by Mark Schoenberg , and a net sale of 15,422 shares made by Jason Drew Smith .
In summary, during the past 3 months, insiders sold 12,000 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 12,000 shares. During the past 18 months, 36,900 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 36,900 shares.
UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
UroGen Pharma Ltd Insider Transactions
Proquest Investments Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Proquest Investments Iv, L.p.. You might contact Proquest Investments Iv, L.p. via mailing address: 2430 Vanderbilt Beach Road, #108 - 190, Naples Fl 34109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
